Fig. 1From: How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practiceData showing the results of treatment with CGRP(r) MoAbs on the main efficacy endpoints in patients with episodic migraineBack to article page